fosrenol 500 mg purutabletti
takeda pharmaceuticals international ag ireland branch - lanthanum (iii) carbonate hydrate - purutabletti - 500 mg - lantaanikarbonaatti
fosrenol 750 mg purutabletti
takeda pharmaceuticals international ag ireland branch - lanthanum (iii) carbonate hydrate - purutabletti - 750 mg - lantaanikarbonaatti
fosrenol 1000 mg purutabletti
takeda pharmaceuticals international ag ireland branch - lanthanum (iii) carbonate hydrate - purutabletti - 1000 mg - lantaanikarbonaatti
atorvastatin orion 10 mg tabletti, kalvopäällysteinen
sun pharmaceutical industries europe b.v. - atorvastatin calcium trihydric - tabletti, kalvopäällysteinen - 10 mg - atorvastatiini
atorvastatin orion 20 mg tabletti, kalvopäällysteinen
sun pharmaceutical industries europe b.v. - atorvastatin calcium trihydric - tabletti, kalvopäällysteinen - 20 mg - atorvastatiini
atorvastatin orion 40 mg tabletti, kalvopäällysteinen
sun pharmaceutical industries europe b.v. - atorvastatin calcium trihydric - tabletti, kalvopäällysteinen - 40 mg - atorvastatiini
atorvastatin orion 80 mg tabletti, kalvopäällysteinen
sun pharmaceutical industries europe b.v. - atorvastatin calcium trihydric - tabletti, kalvopäällysteinen - 80 mg - atorvastatiini
azacitidine stada 25 mg/ml injektiokuiva-aine, suspensiota varten
stada arzneimittel ag - azacitidine - injektiokuiva-aine, suspensiota varten - 25 mg/ml - atsasitidiini
ximluci
stada arzneimittel ag - ranibitsumabi - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - silmätautien - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
etraga 25 mg/ml injektiokuiva-aine, suspensiota varten
stada arzneimittel ag - azacitidine - injektiokuiva-aine, suspensiota varten - 25 mg/ml - atsasitidiini